Peter Löser
Impact in
- Genetics top 5%
- Virus-based gene therapy research
- Molecular Biology top 10%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Viral Infectious Diseases and Gene Expression in Insects
Papers in
-
- Pluripotent Stem Cells Research 13
- CRISPR and Genetic Engineering 12
- Viral Infectious Diseases and Gene Expression in Insects 8
- Genetics 15
- Virus-based gene therapy research 14
- Co-authors
- Mike Strauss (8 shared papers)Volker Sandig (3 shared papers)Anna M. Wobus (3 shared papers)Gary Jennings (1 shared paper)Claus Scheidereit (2 shared papers)Anke Guhr (9 shared papers)Armin Kurtz (7 shared papers)Christian Hofmann (8 shared papers)
- Journals
- Journal of Virology (5 papers)Stem Cell Reports (4 papers)The Journal of Gene Medicine (2 papers)Gene Therapy (2 papers)Stem Cells (2 papers)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Peter Löser
32 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 98
- Genetics 557
- Molecular Biology 1.1k
- Cancer Research 199
- Immunology 222
- Oncology 243
Countries citing papers authored by Peter Löser
This map shows the geographic impact of Peter Löser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Löser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Löser more than expected).
Fields of papers citing papers by Peter Löser
This network shows the impact of papers produced by Peter Löser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Löser. The network helps show where Peter Löser may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Löser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 249 | |
| 2 | 2001 | 230 | |
| 3 | 2005 | 159 | |
| 4 | 2010 | 110 | |
| 5 | 2011 | 108 | |
| 6 | 1999 | 96 | |
| 7 | 2003 | 93 | |
| 8 | 1999 | 86 | |
| 9 | 2006 | 67 | |
| 10 | 2001 | 60 | |
| 11 | 1998 | 59 | |
| 12 | 2009 | 57 | |
| 13 | 2020 | 48 | |
| 14 | 2018 | 47 | |
| 15 | 2002 | 38 | |
| 16 | 2004 | 33 | |
| 17 | 2000 | 30 | |
| 18 | 2004 | 28 | |
| 19 | HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. | 1996 | 28 |
| 20 | 2002 | 21 |
About Peter Löser
Peter Löser is a scholar working on Molecular Biology, Genetics, Physiology, Biomedical Engineering and Infectious Diseases, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Pluripotent Stem Cells Research (13 papers), CRISPR and Genetic Engineering (12 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers), Biomedical Ethics and Regulation (7 papers), 3D Printing in Biomedical Research (5 papers), Viral gastroenteritis research and epidemiology (4 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Genetics (557 citations), Molecular Biology (1.1k citations), Cancer Research (199 citations), Immunology (222 citations) and Oncology (243 citations). Peter Löser has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Mike Strauss, Volker Sandig, Anna M. Wobus, Gary Jennings, Claus Scheidereit, Anke Guhr, Armin Kurtz, Christian Hofmann, Gerald W. Both and Bernd Dörken. Their work appears in journals such as Journal of Virology, Stem Cell Reports, The Journal of Gene Medicine, Gene Therapy and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.